CIAM
EDIT icon

Caitong International Asset Management’s Editas Medicine EDIT Stock Holding History

Caitong International Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-642
Closed -$1.59K – 3116
2026
Q1 		$1.59K Buy
+642
New +$1.36K ﹤0.01% 1292
2025
Q1 		– Sell
-286
Closed -$363 – 2257
2024
Q4 		$363 Buy
+286
New +$729 ﹤0.01% 1505

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Caitong International Asset Management's EDIT Position: Q2 2026 in Review

Caitong International Asset Management sold out of Editas Medicine (EDIT) in Q2 2026, closing a stake of 642 shares — an estimated $1.59K sold.

Caitong International Asset Management first reported a position in EDIT in Q4 2024 and held it in 2 quarters. The position peaked at $1.59K in Q1 2026. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Caitong International Asset Management reported no remaining Editas Medicine position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 642 Editas Medicine shares in Q2 2026, an estimated $1.59K.
  • Caitong International Asset Management first reported a position in Editas Medicine in Q4 2024 and held it in 2 quarters.
  • Caitong International Asset Management's Editas Medicine position peaked at $1.59K in Q1 2026.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.